Advertisement
Person › Details
Guy-Charles Fanneau de la Horie (Pherecydes Pharma S.A. (Euronext Paris: ALPHE))
Fanneau de la Horie, Guy-Charles (Pherecydes Pharma 201602– CEO before PathoQuest + Neovacs + Biogen)
Organisation | Pherecydes Pharma S.A. (Euronext Paris: ALPHE) | |
Former/major organisation | PathoQuest SAS | |
Product | anti-infective drug | |
Record changed: 2021-09-06 |
Advertisement
More documents for Guy-Charles Fanneau de la Horie
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top